Editorial · 2023 · Open access

Mendelian Randomization Studies in Endocrinology: Raising the Quality Bar for Submissions and Publications in The Journal of Clinical Endocrinology & Metabolism

Alisa Devedzic Kjaergaard, George Davey Smith, Paul M. Stewart

The Journal of Clinical Endocrinology & Metabolism, 109(1), 1–3 · Published 5 October 2023 · DOI 10.1210/clinem/dgad569

Open PDFView at the publisherCite this paper

In brief

“Mendelian Randomization Studies in Endocrinology: Raising the Quality Bar for Submissions and Publications in The Journal of Clinical Endocrinology & Metabolism” is an 2023 editorial by Alisa Devedzic Kjaergaard and 2 co-authors, published in The Journal of Clinical Endocrinology & Metabolism. OpenAlex counts 27 citations as of 18 November 2026. It is open access: the full text is free to read at The Journal of Clinical Endocrinology & Metabolism.

Citations
27
Most cited in
2025 (15)
References
9
Authors
3

Abstract

Mendelian randomization (MR) is a powerful method for strengthening causal inference using observational epidemiological data through leveraging evidence provided by the particular properties of germline genetic variants [typically single nucleotide polymorphisms (SNPs)] (1). The nomenclature derives from Mendel's laws of heritability and the analogy with randomized controlled trials (RCTs) that exists in the assignment of variants from parents to offspring in within-family designs, which was how the principle as currently applied in epidemiological studies was introduced (1). However, because within-family genotyped data sets were very limited at that time, “approximate MR” within population studies was advanced as a second best (1), and the large majority of current MR studies are of this kind. Genotype is established at conception and thus conventional reverse causation—with a disease process influencing the apparent exposure—is not an issue with genetic variants proxying for the exposure, Furthermore, conventional confounding is much reduced in MR studies, particularly if population stratification is taken into account in the analysis. MR exploits the component of the exposure that is influenced by the genetic variant to examine the effect of the genetically predicted exposure on the outcome, and if the fundamental MR assumption of gene-environment equivalence holds, this can be extrapolated to represent the causal effect of the exposure (however influenced) on the outcome (2). The 3 core assumptions of the instrumental variable implementation of MR are (1) robust SNP-exposure associations, (2) no confounding of the SNP and the outcome, and (3) SNP-outcome effect is entirely mediated by the exposure. The overall causal estimates can be calculated by meta-analyzing the individual SNP Wald ratios, ie, the ratios for SNP-outcome and SNP-exposure associations. This is particularly useful in the context of genome-wide association studies (GWASs). Two sample MR (2SMR) only requires summary statistics (β-coefficients and standard errors) on SNP-exposure and SNP-outcome associations from different GWASs, many of which are publicly available (2). Moreover, freely available software tools and databases, such as the MRC IEU Open GWAS project and the TwoSampleMR R package, have enabled fast and easy performance of 2SMR analyses (3). The power of MR as it relates to uncovering novel mechanistic insight to modifiable and nonmodifiable pathways is well recognized and highlighted by numerous recent publications. In one such multivariable MR study on thyroid function, height and atrial fibrillation (4), causal association between low TSH and increased atrial fibrillation risk was shown to be partly mediated by increased height. Thyroid function (in this case TSH) can be modified throughout life, whereas the effects of TSH mediated through height are established…

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Kjaergaard, A. D., Smith, G. D., & Stewart, P. M. (2023). Mendelian Randomization Studies in Endocrinology: Raising the Quality Bar for Submissions and Publications in The Journal of Clinical Endocrinology & Metabolism. The Journal of Clinical Endocrinology & Metabolism, 109(1), 1–3. https://doi.org/10.1210/clinem/dgad569

MLA 9

Kjaergaard, Alisa Devedzic, et al. “Mendelian Randomization Studies in Endocrinology: Raising the Quality Bar for Submissions and Publications in The Journal of Clinical Endocrinology & Metabolism.” The Journal of Clinical Endocrinology & Metabolism, vol. 109, no. 1, 2023, pp. 1–3. https://doi.org/10.1210/clinem/dgad569.

Chicago

Kjaergaard, Alisa Devedzic, George Davey Smith, and Paul M. Stewart. 2023. “Mendelian Randomization Studies in Endocrinology: Raising the Quality Bar for Submissions and Publications in The Journal of Clinical Endocrinology & Metabolism.” The Journal of Clinical Endocrinology & Metabolism 109 (1): 1–3. https://doi.org/10.1210/clinem/dgad569.

Harvard

Kjaergaard, A. D., Smith, G. D. and Stewart, P. M. (2023) ‘Mendelian Randomization Studies in Endocrinology: Raising the Quality Bar for Submissions and Publications in The Journal of Clinical Endocrinology & Metabolism’, The Journal of Clinical Endocrinology & Metabolism, 109(1), pp. 1–3. doi:10.1210/clinem/dgad569.

IEEE

A. D. Kjaergaard, G. D. Smith, and P. M. Stewart, “Mendelian Randomization Studies in Endocrinology: Raising the Quality Bar for Submissions and Publications in The Journal of Clinical Endocrinology & Metabolism,” The Journal of Clinical Endocrinology & Metabolism, vol. 109, no. 1, pp. 1–3, 2023, doi: 10.1210/clinem/dgad569.

BibTeX

@article{kjaergaard2023mendelian,
  title     = {{Mendelian Randomization Studies in Endocrinology: Raising the Quality Bar for Submissions and Publications in The Journal of Clinical Endocrinology \& Metabolism}},
  author    = {Kjaergaard, Alisa Devedzic and Smith, George Davey and Stewart, Paul M.},
  journal   = {The Journal of Clinical Endocrinology \& Metabolism},
  year      = {2023},
  volume    = {109},
  number    = {1},
  pages     = {1--3},
  doi       = {10.1210/clinem/dgad569},
  url       = {https://doi.org/10.1210/clinem/dgad569}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202311
202455
20251515
202666

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology

  • Mendelian randomization
  • two-sample Mendelian randomization
  • causal inference
  • confounding
  • reverse causality
  • single nucleotide polymorphisms
  • thyroid function
  • atrial fibrillation

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Kjaergaard, A. D., Smith, G. D., & Stewart, P. M. (2023). Mendelian Randomization Studies in Endocrinology: Raising the Quality Bar for Submissions and Publications in The Journal of Clinical Endocrinology & Metabolism. The Journal of Clinical Endocrinology & Metabolism, 109(1), 1–3. https://doi.org/10.1210/clinem/dgad569

How many times has this paper been cited?

27 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at The Journal of Clinical Endocrinology & Metabolism: sign in and open the PDF from this page.

Who wrote this paper?

Alisa Devedzic Kjaergaard, George Davey Smith, Paul M. Stewart.

What is the DOI of this paper?

10.1210/clinem/dgad569, permanently at https://doi.org/10.1210/clinem/dgad569. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.